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POEMS Syndrome is a rare cause of demyelinating and axonal mixed neuropathy. Plasmacytomas are usually seen in POEMS
syndrome and can be osseous or extramedullary. Plasmacytomas presenting as an abscess has not been noted earlier. Our
patient presented with localized hyperpigmented patch on the back and later developed progressive weakness in upper and lower
limbs. Initially serum and urine protein electrophoresis were normal. The patient was thought to have Chronic Inﬂammatory
Demyelinating Polyneuropathy and was treated accordingly without any improvement. Repeat serum protein electrophoresis
showed monoclonal gammopathy. MRI of the back revealed an abscess in the paravertebral soft tissues reaching up to the skin.
Needlebiopsywasconsistentwithplasmacytoma.Later,hedevelopedapurulentfungatinglesioninthelowermidback.Antibiotics
were started and local resection was done followed by radiation. Pathology of the resected mass showed plasmacytoma extensively
involving subcutaneous soft tissue and bone. The patient improved with the treatment. Cystic plasmacytomas and abscess within
the plasmacytoma has not been reported earlier. Whether abscess formation is part of the disease spectrum due to inﬁltration of
overlying tissue or is secondary to localized immunosuppression is unknown. Local treatment of a single plasmacytoma is useful
in ameliorating systemic symptoms.
1.Background
POEMS syndrome also known as osteosclerotic myeloma,
Crow-Fukase syndrome [1] or Takatsuki and Sanada [2]
syndrome is a rare cause of demyelinating and axonal mixed
neuropathy with multiorgan involvement and monoclonal
plasma cell proliferative disorder [3]. It was ﬁrst described
in 1968 by Shimpo [4] and was later given its name by
Bardwick et al. [5]. The acronym POEMS is indicative of
Polyneuropathy, Organomegaly, Endocrinopathy, Mono-
clonal protein and Skin changes [5]. POEMS syndrome
commonly presents chronic progressive polyneuropathy
with a predominant motor disability [1–7]. Osteosclerotic
bone lesions with the evidence of plasma cells inﬁltration
(plasmacytomas) are commonly seen in POEMS syndrome
[1–7]. Solitary osseous plasmacytoma without other features
of POEMS syndrome usually presents as a lytic lesion.
Extramedullary plasmacytomas are relatively rare [8, 9].
Plasmacytomas presenting as an abscess have not been
noted earlier. This could be a manifestation of the localized
immunosuppression. Immunosuppression in POEMS syn-
drome has not been well described in literature and bacterial
infections as initial presentation has not been seen.
We are presenting a unique case of POEMS syndrome
with a solitary plasmacytoma which presented as an abscess
involving the spinous process and overlying skin. The
patient’s symptoms improved signiﬁcantly afterthe resection
of plasmacytoma.
2. Case Presentation
A 51-year-old African American obese male with history of
diabetes and hypertension presented with a localized hyper-
pigmented patch on the back which was biopsied and was
found to be interstitial dermatitis with inﬂammatory mor-
phea. It was thought to be a benign lesion, and the patient2 ISRN Hematology
was started on a topical steroid cream. No other intervention
was done at that time. About nine months later, he came
backwiththecomplainofprogressiveweaknessinupperand
lowerlimbsandfrequentfalls.Hewasunabletowalkwithout
a walker. He also had tingling, numbness, and burning in
his feet. It was also noted at that time that his skin patch in
the back has increased in size and he had another hyperpig-
mented patch in right-lower quadrant of his abdomen.
Onphysicalexaminationhehadstablevitalsigns.Hehad
a hyperpigmented patch with regular borders approximately
9×2.5cm on the right lower quadrant of the abdomen
and a hyperpigmented patch with hyperkeratosis on the
lower midback measuring about 47×15 cm. He also had
hepatomegaly. On neurological exam he had motor and
sensory loss in the extremities. His power was 4/5 at elbow
bilaterally on both ﬂexion and extension and 4/5 at the knee
bilaterally on ﬂexion and extension.
The patient’s initial workup showed platelet count of
633k/µL (normal 130–400k/µL). Lumbar puncture was
grossly acellular with abnormal glucose (139mg/dL, nor-
mal 40–70mg/dL) and protein (99mg/dL, normal 10–
60mg/dL). Initially serum and urine protein electrophore-
sis as normal. Electromyogram was done, which showed
demyelinating neuropathy with evidence of conduction
block and temporal dispersion. Bone marrow biopsy did not
show any atypical plasma cells. Plasmacytosis (5%) was seen
on bone marrow examination.
The patient was initially thought to have chronic
inﬂammatory demyelinating polyneuropathy (CIDP) and
was started on high-dose steroids, and later intravenous
immunoglobulin (IVIG) was given. There was no improve-
ment in his condition.
Repeat serum protein electrophoresis showed small
gamma spike and monoclonal gammopathy (IgG type
lambda 19.4% (normal 9%–18%)).Urine electrophoresis
showed light chain M protein (Figure 1).
MRI of the back was done to look for spinal causes of leg
weakness which incidentally revealed 6cm×3.5cm×4cm
abscess in the posterior paravertebral soft tissues reaching up
in the skin causing inﬂammation around it with osteomyeli-
tis of the L1 spinous process. No spinal nerve compression or
epidural involvement was noted (Figure 2).
Fluoroscopy-guided aspiration of the abscess revealed
hemorrhagic ﬂuid which did not grow anything on culture.
patient reported no change in his condition. The patient
was still being treated as CIDP, and he was started on
plasmapheresis for 10 days. At this point, it was thought that
the gammopathy was probably monoclonal gammopathy of
undetermined signiﬁcance.
The patient continued to worsen neurologically. A whole
body X-ray scan was done which revealed a lytic lesion
at L2. Subsequent to that a CT scan to evaluate the lytic
lesion and CT-guided ﬁne needle aspiration (FNA) of the
mass growing from L1 spinous process was done which was
consistent with plasmacytoma on pathology. After the FNA
he developed an infected purulent discharging fungating
lesion in the lower midback at the site of hyperpigmentation.
He was started on piperacillin/tazobactam and vancomycin.
Antibiotics were narrowed down to ciproﬂoxacin and later
Figure 1: Serum protein electrophoresis of the patient showing IgG
spike (arrow).







Figure 2: MRI of lumbar spine showing abscess at L1 (arrow).
piperacillin based on the culture results which grew Pseu-
domonas and coagulase-negative Staphylococcus.Ar e p e a t
MRI of the back showed interval increase in size of the
abscess noted previously.
The patient underwent lumbar subcutaneous mass exci-
sion, L1 spinous process excision, and partial laminectomy.
Pathology of the resected mass from L1 spinous process
showed plasmacytoma extensively involving subcutaneous
soft tissue and portions of bone. He also received radiation
to the lumbar area.He wascontinued on piperacillin for four
more weeks after discharge. The patient responded well to
the treatment and showed increased strength in extremities.
Skin changes on his back and abdomen also resolved.
Thrombocytosis resolved and gamma proteins decreased
from 1.4g/dL to 0.9g/dl (Ref. range 0.5–1.4g/dl). He later
developed weakness in upper arms with discovery of a lytic
lesion in the cervical spine for which he received 4000cGy
radiation using intensity-modulated radiation therapy. The
patient has apparently been stable since his radiotherapyISRN Hematology 3
Figure 3: Recent serum protein electrophoresis of the patient
showing resolution of IgG spike.
whichwasdonearound8yearsago.Hisrecentserumprotein
electrophoresis is normal (Figure 3).
3. Discussion and Conclusion
Plasma cell neoplasms account for approximately 1% to
2% of human malignancies and occur at a rate of about
3.5/100,000 per year [8]. Less than 10% of patients with
plasma cell neoplasms present with a solitary plasmacy-
toma that may be either extramedullary or osseous [8, 9].
Extramedullary plasmacytoma (EMP) is a rare disease which
typically presents as a well-localized submucosal mass or
swelling. EMPs often have polypoidal conﬁguration and are
more common in head and neck region [9]. Cutaneous
plasmacytomas are rare EMPs and can be primary or
secondary. The secondary cutaneous plasmacytomas arise
from underlying bony lesion.
Plasmacytomas are known manifestations in POEMS
syndrome and can be typically diﬀerentiated from solitary
plasmacytomas by the presence of other clinical features
and also by the presence of osteosclerotic bony lesions
in POEMS syndrome instead of only osteolytic lesions in
solitary plasmacytomas.
Our patient, who presented with neuropathy and skin
changes, had an abscess at L1 spine which was detected
incidentally on the MRI which was performed to look for
spinal compression and to rule out other causes for lower
extremitiesweakness.Thebiopsyofthelesionconﬁrmedthat
it was a plasmacytoma.
Cystic plasmacytomas and abscess arising within the
plasmacytoma and underlying osteomyelitis as seen in our
patient has not been reported earlier, and to the best of
our knowledge, this is the ﬁrst such case reported. Whether
abscess formation is part of the disease spectrum due to
inﬁltration of overlying tissue or is secondary to localized
immunosuppression is unknown.
POEMS syndrome remains a diﬃcult and rare diagnosis.
Neuropathy is present in almost all the cases of POEMS syn-
drome. First-line treatment of neuropathic pain in plasma
cell dyscrasias is Ca channel alpha (2) delta ligands (i.e.,
gabapentin and pregabalin) and certain antidepressants (i.e.,
tricyclic antidepressants and dual reuptake inhibitors of both
serotonin and norepinephrine) [10].
In the case of solitary plasmacytoma early diagnosis,
proper treatment with radiation is necessary to prevent
unnecessary complications. Surgical resection can be con-
sidered as a possible treatment in case there are infectious
complications such as an abscess as observed in our patient.
As seen in our case local treatment of a single plasmacytoma
with surgical removal and radiation is useful in ameliorating
the systemic symptoms [11, 12]. Six weeks of antibiotic
therapy was useful to treat the abscess and osteomyelitis.
POEMS syndrome has a chronic course, and survival
is three times greater compared to multiple myeloma.
MediansurvivalofPOEMSsyndromeisaround165months,
regardless of how many syndrome features, bone lesions, or
plasma cells are present at the time of diagnosis. Additional
features of the syndrome often develop in future, but the
complications of classic multiple myeloma rarely develops.
Even patients with multiple bone lesions or those with more
than 10% plasma cells do not progress to overt multiple
myeloma. Cardiorespiratory failure and pneumonia are the
common causes of death in POEMS syndrome [6].
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